This study aims to evaluate the effects of a fiber-enriched, sodium-controlled enteral nutrition formula on glycemia, blood pressure, and nutritional status in long-term care residents with diabetes receiving tube feeding. Participants receive the enteral formula as their sole source of nutrition for 3 months, followed by a 1-month post-intervention follow-up period. Clinical outcomes including metabolic parameters, blood pressure, and safety indicators are assessed.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Systolic and diastolic blood pressure
Timeframe: baseline, 3 months, and 4 months
Fasting blood glucose
Timeframe: Baseline, 3 months, and 4 months
Glycated hemoglobin (HbA1c)
Timeframe: Baseline, 3 months, and 4 months
Serum albumin
Timeframe: Baseline, 3 months, and 4 months
Serum total protein
Timeframe: Baseline, 3 months, and 4 months
Total cholesterol
Timeframe: Baseline, 3 months, and 4 months
Triglycerides
Timeframe: Baseline, 3 months, and 4 months
High-density lipoprotein cholesterol (HDL-C)
Timeframe: Baseline, 3 months, and 4 months
Low-density lipoprotein cholesterol (LDL-C)
Timeframe: Baseline, 3 months, and 4 months
Geriatric Nutritional Risk Index (GNRI)
Timeframe: Baseline, 3 months, and 4 months
Subjective Global Assessment (SGA)
Timeframe: Baseline, 3 months, and 4 months